BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1824269)

  • 1. Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy.
    Kwak LW; Campbell MJ; Zelenetz AD; Levy R
    Blood; 1991 Nov; 78(10):2768-72. PubMed ID: 1824269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active immunization of murine allogeneic bone marrow transplant donors with B-cell tumor-derived idiotype: a strategy for enhancing the specific antitumor effect of marrow grafts.
    Kwak LW; Pennington R; Longo DL
    Blood; 1996 Apr; 87(7):3053-60. PubMed ID: 8639929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin.
    Kwak LW; Campbell MJ; Zelenetz AD; Levy R
    Blood; 1990 Dec; 76(11):2411-7. PubMed ID: 2257310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
    Kwak LW; Campbell M; Levy R
    Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor resistance induced by syngeneic bone marrow transplantation and enhanced by interleukin 2: a model for the graft versus leukemia reaction.
    Kwak LW; Campbell MJ; Levy R
    Cancer Res; 1992 Aug; 52(15):4117-20. PubMed ID: 1638524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.
    Hornung RL; Longo DL; Bowersox OC; Kwak LW
    J Natl Cancer Inst; 1995 Sep; 87(17):1289-96. PubMed ID: 7544833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma.
    Davis TA; Hsu FJ; Caspar CB; van Beckhoven A; Czerwinsk DK; Liles TM; Taidi B; Benike CJ; Engleman EG; Levy R
    Biol Blood Marrow Transplant; 2001; 7(9):517-22. PubMed ID: 11669219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease.
    Bryson JS; Jennings CD; Lowery DM; Carlson SL; Pflugh DL; Caywood BE; Kaplan AM
    Bone Marrow Transplant; 1999 Feb; 23(4):363-72. PubMed ID: 10100580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts.
    Mumcuoglu M; Zakay-Rones Z; Parag G; Weiss L; Slavin S
    Bone Marrow Transplant; 1987 Dec; 2(4):403-12. PubMed ID: 3332187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery.
    Tiberghien P; Longo DL; Wine JW; Alvord WG; Reynolds CW
    Blood; 1990 Oct; 76(7):1419-30. PubMed ID: 2207317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
    Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
    Tomita Y; Sachs DH; Sykes M
    Blood; 1994 Feb; 83(4):939-48. PubMed ID: 7906567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A murine B cell lymphoma expressing human HER2 / neu undergoes spontaneous tumor regression and elicits antitumor immunity.
    Penichet ML; Dela Cruz JS; Challita-Eid PM; Rosenblatt JD; Morrison SL
    Cancer Immunol Immunother; 2001 Feb; 49(12):649-62. PubMed ID: 11258791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
    Kwak LW; Young HA; Pennington RW; Weeks SD
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10972-7. PubMed ID: 8855293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of immunological tolerance in full major and multiminor histocompatibility-disparate mice using a mixed bone marrow transplantation model.
    el Badri NS; Good RA
    Proc Soc Exp Biol Med; 1994 Jan; 205(1):67-74. PubMed ID: 8115352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
    Bohlen H; Thielemanns K; Tesch H; Engert A; Wolf HJ; van Camp B; Urbain J; Diehl V
    Cytokines Mol Ther; 1996 Dec; 2(4):231-8. PubMed ID: 9384709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors.
    Shouval D; Adler R; Ilan Y
    Hepatology; 1993 Jun; 17(6):955-9. PubMed ID: 8514268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation.
    Blank M; Tomer Y; Slavin S; Shoenfeld Y
    Scand J Immunol; 1995 Aug; 42(2):226-34. PubMed ID: 7631156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors.
    Ilan Y; Nagler A; Shouval D; Ackerstein A; Or R; Kapelushnik J; Adler R; Slavin S
    Clin Exp Immunol; 1994 Aug; 97(2):299-302. PubMed ID: 8050180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced augmentation of host resistance to histocompatible tumor in mice. Detection of a graft antitumor effect of syngeneic bone marrow transplantation.
    Kwak LW; Grand LC; Williams RM
    Transplantation; 1991 Jun; 51(6):1244-8. PubMed ID: 1904663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.